Cash to Monthly Cash Expenses Ratio Amicus Therapeutics, Inc., is a biopharmaceutical company that develops drugs for the treatment of various diseases, including Parkinson's disease. Amicus Therapeutics reported the following financial dota (in thousands) for three recent years: a. Determine the monthly cash expenses for Year 3, Year 2, and Year 1 (in thousands), Round to one decimal place. b. Determine the ratio of cash to manthily cash expenses for Year 3, Year 2, and Year 1 as of December 31. Round to one decimal place. c. Based on (a) and (b), which of the following statements is correct. 1. Amicus has been able to support its operations by issuing additional stock. However, its negative cash flows have increased from Year 1 to Year 3. 2. Amicus has been able to support its operations generating positive cash flows. Its pesitive cash flows have increased from Year 1 to Year 3 . 3. Amicus has been able to support its operations generoting positive cash fows. However, the cash flows generated are used to purchase short term investment